openPR Logo
Press release

Vaccine Management Solution Market Trends, Opportunity & Forecast (Includes Business Impact of COVID-19): Fact.MR Study

02-02-2021 01:53 AM CET | IT, New Media & Software

Press release from: Fact.MR

Vaccine Management Solution Market Trends, Opportunity &

The global vaccine management solution market was valued at over US$ 140 million in 2019, and is anticipated to reach nearly US$ 590 million by 2030. The spread of COVID-19 has brought about a rise in demand for vaccine management solutions. The pandemic has led to additional gain of US$ 5 million in 2020, and the same is expected to follow in 2021. However, as the years go by, when most buyers had purchased these vaccine management solutions, companies in this space will gain revenue only through license renewal, and this is when market growth won’t be as high as it is now.

To remain ‘ahead’ of your competitors, request a sample: https://www.factmr.com/connectus/sample?flag=S&rep_id=5466

Key Takeaways from Vaccine Management Solution Market Study

North America is dominating the global vaccine management solution market with a share of around 35% in 2019, primary reason being, well-established ICT (information, communication & technology) companies in the region.

The vaccine management solution market in excepted to experience the highest CAGR in the Middle East & Africa and Latin America. This is because active international organizations support a complete global vaccine action plan.

The global market is projected to surge at an impressive CAGR of over 17% through 2030.

The COVID-19 pandemic is one of the main factors causing an increase in demand for vaccine management solutions, globally. Focus of governments on improving digital infrastructure is another reason assisting the growth of the vaccine management solution market.

“A large share of the vaccine management solution market is managed by government organizations. Companies can focus on covering countries having insufficient resources to cover immunization programs,” says a Fact.MR analyst.

Product Launches to Enhance Market Resiliency

Key players operating in the vaccine management solution market space are Deloitte, Infosys, Accenture, Salesforce, Conduent, UL, Omnisys, and PreCheck.

Some of the recent product launches include:

Owing to opportunity provided by the COVID-19 pandemic, Infosys recently acquired Utah-based company Simplus, which is providing vaccine management solutions.

Omnisys’ OmniLINK vaccine management solution (VMS), launched in 2020, particularly focuses on pharmacy-administered immunizations.

Following the COVID-19 pandemic, Epazz launched numerous solutions in 2020. Some of them are vaccine management solutions, social distancing featured software, video interviewing, featured applicant tracking systems, etc.

For critical insights on this market, request for Methodology here: https://www.factmr.com/connectus/sample?flag=RM&rep_id=5466

Find More Valuable Insights on Vaccine Management Solution Market

Fact.MR, in its new offering, presents an unbiased analysis of the global vaccine management solution market, presenting historical demand data (2015-2019) and forecast statistics for the period of (2020-2030). The study divulges essential insights on the vaccine management solution market on the basis of component (solution [inventory management, program management, clinical vaccine management, data management, public engagement, organizational support] and services [managed services and professional services]), model (platform-based solutions and one-point solutions), subscription (new subscribers and renewed subscribers), and end use (public and private), across 7 key regions of the world.

Contact Us

Fact.MR

Unit No: AU-01-H

Gold Tower (AU)

Plot No: JLT-PH1-I3A

Jumeirah Lakes Towers, Dubai

United Arab Emirates

Contact: +353-1-6111-593

Web: https://www.factmr.com/

About Us:

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Vaccine Management Solution Market Trends, Opportunity & Forecast (Includes Business Impact of COVID-19): Fact.MR Study here

News-ID: 2234413 • Views:

More Releases from Fact.MR

Insulated Drinkware Market to Hit USD 2.57 Billion by 2033 | YETI, Thermos L.L.C., Hydro Flask Lead - Fact.MR
Insulated Drinkware Market to Hit USD 2.57 Billion by 2033 | YETI, Thermos L.L.C …
The global insulated drinkware market was valued at US$ 1.39 billion in 2023 and is forecasted to expand at a 6.3% CAGR over the next ten years. Worldwide sales of insulated drinkware are projected to reach US$ 2.57 billion by 2033-end.This robust growth is driven by increasing consumer awareness of sustainability, rising participation in outdoor activities, and the growing demand for reusable, eco-friendly products amid bans on single-use plastics. The market
Digital Twin Market is Growing at a CAGR of 34.3% d by 2033 | Key Players: ABB Ltd, ANSYS, Inc, AT&T Inc, AVEVA Group plc, Bentley Systems
Digital Twin Market is Growing at a CAGR of 34.3% d by 2033 | Key Players: ABB L …
Digital Twin Market is valued at USD 5 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 34.3%, reaching USD 95 billion by 2033. This explosive growth is driven by the increasing adoption of digital twins across industries to optimize operations, reduce costs, and enhance decision-making through virtual replicas of physical assets. Digital twins integrate IoT, AI, and data analytics to simulate real-world
Hemato Oncology Testing Market is Forecasted to Reach USD 23.64 Billion by 2033 | Fact.MR Report
09-02-2025 | Health & Medicine
Fact.MR
Hemato Oncology Testing Market is Forecasted to Reach USD 23.64 Billion by 2033 …
The global hemato oncology testing market is valued at USD 4.33 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 18.5%, reaching USD 23.64 billion by 2033. This rapid growth is driven by the increasing prevalence of blood-related cancers, such as lymphoma and leukemia, and advancements in diagnostic technologies like next-generation sequencing (NGS) and polymerase chain reaction (PCR). Hemato oncology testing plays a
Osseointegration Implants Market is Anticipated to Reach USD 6.85 Billion by 2035
09-02-2025 | Health & Medicine
Fact.MR
Osseointegration Implants Market is Anticipated to Reach USD 6.85 Billion by 203 …
Osseointegration Implants Market is poised for robust growth, with its valuation projected to rise from USD 3.17 billion in 2025 to USD 6.85 billion by 2035, reflecting a compound annual growth rate (CAGR) of 8%. This expansion is driven by the increasing prevalence of orthopedic and dental disorders, such as osteoarthritis, rheumatoid arthritis, and edentulism, which necessitate advanced implant solutions. Osseointegration implants, which fuse directly with bone to provide stable

All 5 Releases


More Releases for Vaccine

Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Download Sample PDF at  https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis:  AstraZeneca  Bharat Biotech  Dynavax Technologies Corporation  GlaxoSmithKline  Johnson & Johnson  Merck and Co  Novartis  Pfizer  Sanofi Pasteur  Serum Institute of India The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion